11C-PK11195 PET imaging and white matter changes in Parkinson’s disease dementia

11Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There is evidence of increased microglial activation in Parkinson’s disease (PD) as shown by in vivo PET ligand such as 11C-PK11195. In addition, diffusion tensor imaging (DTI) imaging reveals widespread changes in PD, especially when the associated dementia develops. In the present case series, we studied five subjects with Parkinson’s disease dementia (PDD). Our findings suggest that while DTI metrics mirror cognitive severity, higher 11C-PK11195 binding seems to be associated with a relative preservation of both white matter tracts and cognition. Longitudinal studies are warranted to tackle the complex relationship between microglial activation and structural abnormalities in neurodegenerative conditions.

Cite

CITATION STYLE

APA

Nicastro, N., Surendranathan, A., Mak, E., Rowe, J. B., & O’Brien, J. T. (2019). 11C-PK11195 PET imaging and white matter changes in Parkinson’s disease dementia. Annals of Clinical and Translational Neurology, 6(10), 2133–2136. https://doi.org/10.1002/acn3.50877

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free